XML 33 R13.htm IDEA: XBRL DOCUMENT v3.25.0.1
Investments
12 Months Ended
Dec. 31, 2024
Investments, Debt and Equity Securities [Abstract]  
Investments

3. Investments

The carrying value and amortized cost of the Company’s investments, summarized by major security type, consisted of the following (in thousands):

 

 

December 31, 2024

 

 

 

Amortized
Cost

 

 

Unrealized
Gains

 

 

Unrealized
Losses

 

 

Estimated
Fair Value

 

U.S. Treasury notes

 

$

245,584

 

 

$

319

 

 

$

 

 

$

245,903

 

Government sponsored enterprise securities

 

 

190,452

 

 

 

157

 

 

 

(108

)

 

 

190,501

 

 

 

$

436,036

 

 

$

476

 

 

$

(108

)

 

$

436,404

 

 

 

 

December 31, 2023

 

 

 

Amortized
Cost

 

 

Unrealized
Gains

 

 

Unrealized
Losses

 

 

Estimated
Fair Value

 

U.S. Treasury notes

 

$

75,315

 

 

$

47

 

 

$

(28

)

 

$

75,334

 

Government sponsored enterprise securities

 

 

174,867

 

 

 

119

 

 

 

(112

)

 

 

174,874

 

 

 

$

250,182

 

 

$

166

 

 

$

(140

)

 

$

250,208

 

The Company has classified all of its available-for-sale investment securities, including those with maturities beyond one year, as current assets on its consolidated balance sheets based on the highly liquid nature of the investment securities and because these investment securities are considered available for use in current operations. The following table summarizes the contract maturity of the available-for-sale securities we held as of December 31, 2024:

One year or less

 

 

79

%

After one year but within two years

 

 

21

%

Total

 

 

100

%

As of December 31, 2023, all of the Company’s available-for-sale investment securities had contractual maturity dates of less than one year. The Company has classified all equity securities as other assets on its consolidated balance sheets.

At December 31, 2024 and 2023, the Company had 17 and 21 securities, respectively, in an unrealized loss position. The following table presents gross unrealized losses and fair value for those available-for-sale investments that were in an unrealized loss position as of December 31, 2024 and December 31, 2023, aggregated by investment category and length of time that individual securities have been in a continuous loss position (in thousands):

 

 

Less Than 12 Months

 

 

12 Months or Greater

 

 

Total

 

 

 

 

Estimated
Fair Value

 

 

Unrealized
Losses

 

 

Estimated
Fair Value

 

 

Unrealized
Losses

 

 

Estimated
Fair Value

 

 

Unrealized
Losses

 

 

December 31, 2024

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Government sponsored enterprise securities

 

$

84,390

 

 

$

(108

)

 

$

 

 

$

 

 

$

84,390

 

 

$

(108

)

 

Total

 

$

84,390

 

 

$

(108

)

 

$

 

 

$

 

 

$

84,390

 

 

$

(108

)

 

December 31, 2023

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

U.S. Treasury notes

 

$

41,366

 

 

$

(28

)

 

$

 

 

$

 

 

$

41,366

 

 

$

(28

)

 

Government sponsored enterprise securities

 

 

108,587

 

 

 

(112

)

 

 

 

 

 

 

 

 

108,587

 

 

 

(112

)

 

Total

 

$

149,953

 

 

$

(140

)

 

$

 

 

$

 

 

$

149,953

 

 

$

(140

)

 

During the first quarter of 2023, the Company made a sale of all of its investments in commercial paper. The proceeds from sales of these securities were $183.0 million and net realized losses from the related sales were $0.5 million. There were no sales of available-for-sale investment securities in 2024.

At each reporting date, the Company performs an evaluation of impairment to determine if any unrealized losses are the result of credit losses. Impairment is assessed at the individual security level. Factors considered in determining whether a loss resulted from a credit loss or other factors include the Company’s intent and ability to hold the investment until the recovery of its amortized cost basis, the extent to which the fair value is less than the amortized cost basis, the length of time and extent to which fair value has been less than the cost basis, the financial condition of the issuer, any historical failure of the issuer to make scheduled interest or principal payments, any changes to the rating of the security by a rating agency, any adverse legal or regulatory events affecting the issuer or issuer’s industry, any significant deterioration in economic conditions.

The Company does not intend to sell the investment in unrealized loss position and it is unlikely that the Company will be required to sell the investment before the recovery of its amortized cost basis. Based on its evaluation, the Company determined its year-to-date credit losses related to its available-for-sale securities were immaterial at December 31, 2024.